Cosmetics & Aesthetic Product Development
Quantitative, non-invasive insight for cosmetic innovation
Collagen content • Epidermal thickness • Skin roughness • Blood vessel density
OCT skin imaging to validate efficacy, support claims and accelerate time-to-market
VivoSight Dx Pro delivers rapid, non-invasive and repeatable OCT imaging that enables objective measurement of skin health, and cosmetic and aesthetic treatment effects — from early development through commercialisation.
VivoTools pre- and post-treatment skin roughness quantification
Accelerate data-driven cosmetic development
VivoSight Dx Pro replaces subjective grading with quantitative, repeatable OCT metrics, reducing uncertainty, shortening development cycles and strengthening claims substantiation.
Designed for cosmetic and aesthetic research
- Device cleared for use in clinical settings
- Completely non-invasive — ideal for repeated assessment of skin quality, skin health, and photoaging
- Full 3D OCT scans acquired in just 15 seconds
- Repeatable measurements for longitudinal monitoring
- Automated quantitative analysis to accelerate development programmes
- Highly cost-effective compared with subjective grading and expert panels
Fast, simple skin imaging
“As a CRO in cosmetics and dermatology, our clients are increasingly seeking objective quantitative measurement of skin effects during product development and as an aid to innovation and claims validation. VivoSight OCT provides a fast and straightforward way of accurately monitoring key measures such as epidermal thickness, skin roughness and blood vessel density with a simple 15 second scan.“
Lily Jiang, PhD, Global Scientific Advisor, SGS Cosmetics & Hygiene.
Quantify treatment effects — in real time
VivoSight Dx Pro enables direct visualisation and objective measurement of treatment-induced skin changes, supporting innovation, optimisation and claims validation.
With the optional VivoTools™ skin analysis software, powerful quantitative metrics can be extracted from each scan, including:
- Dermal brightness — a proxy measure for collagen content
- Skin surface roughness — including average roughness (Ra) and peak-to-trough (Rz)
- Epidermal thickness — averaged across the full scan area
- Vascular network — vessel diameter and density by depth
These measurements provide repeatable, quantitative endpoints suitable for both internal decision-making and external substantiation.
Unrivalled visualisation
Unrivalled visualisation
Quantify Vascular Density by depth
Measure Epidermal thickness
Quantify peak and average skin surface-roughness
Assess Collagen changes through Dermal Brightness proxy
Turn cosmetic efficacy into quantitative evidence
Replace subjective grading with objective OCT metrics that support claims and accelerate time-to-market.
Build confidence in claims and outcomes
VivoSight supports formulation optimisation, clinical endpoints, regulatory submissions and data-backed consumer claims through objective, non-invasive skin metrics.
Transform cosmetic development with VivoSight
Reduce subjectivity. Strengthen claims. Accelerate innovation.
From early-stage innovation to late-stage validation and commercialisation, VivoSight Dx Pro provides objective, repeatable insight into skin treatment effects — in real time and without invasiveness.
VivoSight measurements are for investigational use only.